Brief: Chimeric Therapeutics Announces A$8.4 MLN Funding To Drive CHM CDH17
23/12/2025 01:21
Dec 23 (Reuters) - Chimeric Therapeutics Ltd CHM.AX: $8.4 M FUNDING TO DRIVE CHM CDH17 AND RESIGNATION OF CMO SHARES TO BE ISSUED VIA TWO TRANCHES AT A$0.003 PER SHARE ALL FIGURES IN AUD Further company coverage: CHM.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial